The Patent Finder

Critical Outcome Technologies Inc.

Also on record
Records under this name other than the patents Critical Outcome Technologies Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Back to Critical Outcome Technologies Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,895,556Compounds and method for treatment of cancer
Lapsed on the fee record
Ended Nov 25, 2022 · USPTO record
Lapsed on the fee recordEnded Nov 25, 2022USPTO record
US 8,822,475Compounds and method for treatment of cancer
Lapsed on the fee record
Ended Sep 2, 2022 · USPTO record
Lapsed on the fee recordEnded Sep 2, 2022USPTO record
US 7,629,347Protein tyrosine kinase inhibitors
Formerly held
Lapsed on the fee record
Ended Dec 8, 2021 · USPTO record
Lapsed on the fee recordEnded Dec 8, 2021USPTO record
US 8,580,792Inhibitor compounds and cancer treatment methods
Lapsed on the fee record
Ended Nov 12, 2021 · USPTO record
Lapsed on the fee recordEnded Nov 12, 2021USPTO record
US 7,585,866Protein tyrosine kinase inhibitors
Lapsed on the fee record
Ended Sep 8, 2021 · USPTO record
Lapsed on the fee recordEnded Sep 8, 2021USPTO record
US 8,466,151Compounds and method for treatment of cancer
Lapsed on the fee record
Ended Jun 18, 2021 · USPTO record
Lapsed on the fee recordEnded Jun 18, 2021USPTO record
US 9,624,220Compounds and method for treatment of HIV
Lapsed on the fee record
Ended Apr 18, 2021 · USPTO record
Lapsed on the fee recordEnded Apr 18, 2021USPTO record
US 8,420,643Compounds and method for treatment of cancer
Lapsed on the fee record
Ended Apr 16, 2021 · USPTO record
Lapsed on the fee recordEnded Apr 16, 2021USPTO record
US 8,367,675Compounds and method for treatment of cancer
Formerly held
Lapsed on the fee record
Ended Feb 5, 2021 · USPTO record
Lapsed on the fee recordEnded Feb 5, 2021USPTO record
US 8,252,800Protein tyrosine kinase inhibitors
Lapsed on the fee record
Ended Aug 28, 2020 · USPTO record
Lapsed on the fee recordEnded Aug 28, 2020USPTO record
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited